Recombinant human VLDL Receptor   

Very low density lipoprotein receptor; VLDL R; VLDLR; VLDL-R; VLDLRCH.    

濃度：1mg/ ml

來(lái)源：Recombinant Human

純度：≥95% SDS-PAGE

表達(dá)系統(tǒng)：HEK 293 cells

標(biāo)簽：His tag C-Terminus

蛋白長(zhǎng)度：Full length protein

內(nèi)毒素水平：<1.000 Eu/µg

純化方法：HPLC

應(yīng)用：SDS-PAGE，Western blot，ELISA

Biological activity,immunology research

保存：-20℃

保質(zhì)期：1年

VLDL (very low density lipoprotein) cholesterol is one of the three major types of cholesterol found in blood. VLDL receptor plays an essential role in triglyceride metabolism. It binds VLDL and transports it into cells by endocytosis. In order to be internalized, the receptor-ligand complexes must first cluster into clathrin coated pits. Binding to Reelin induces tyrosine phosphorylation of Dab1 and modulation of Tau phosphorylation.

產(chǎn)品名稱(chēng)：Rabbit Anti-VLDL Receptor  antibody

Rabbit Anti-VLDL Receptor  

別名：Very low density lipoprotein receptor; VLDL R; VLDLR; VLDL-R; VLDLRCH.       

來(lái)源：Rabbit

克隆類(lèi)型：Polyclonal

濃度：1mg/ml

亞型：IgG

應(yīng)用： WB=1:1000-1:2000,Elisa=1:1000-1:2000,IHC-P=1:100-500,IHC-F=1:100-500,ICC/IF=1:100-500,IF=1:100-500

反應(yīng): Human (predicted: Mouse,Rat,Rabbit,Pig,Dog,Horse)

理論分子量：93kDa

免疫原：KLH conjugated synthetic peptide derived from human VLDL Receptor

保存：-20℃
保質(zhì)期：1年

單克隆抗體

產(chǎn)品名稱(chēng)：Anti-VLDL Receptor antibody

Mouse Anti-VLDL Receptor 

別名：Very low density lipoprotein receptor; VLDL R; VLDLR; VLDL-R; VLDLRCH.   

來(lái)源：Mouse

克隆類(lèi)型：Monoclonal

濃度：1mg/ml

亞型：IgG

應(yīng)用： WB=1:1000-1:2000,Elisa=1:1000-1:2000,IHC-P=1:100-500,IHC-F=1:100-500,ICC/IF=1:100-500,IF=1:100-500

反應(yīng): Human

理論分子量：93kDa

免疫原：KLH conjugated synthetic peptide derived from human VLDL Receptor

保存：-20℃
保質(zhì)期：1年

VLDL (very low density lipoprotein) cholesterol is one of the three major types of cholesterol found in blood. VLDL receptor plays an essential role in triglyceride metabolism. It binds VLDL and transports it into cells by endocytosis. In order to be internalized, the receptor-ligand complexes must first cluster into clathrin coated pits. Binding to Reelin induces tyrosine phosphorylation of Dab1 and modulation of Tau phosphorylation.